BRD7 and lung adenocarcinoma: Since then, decreased expression of BRD7 has been reported in many other human cancers including breast cancer [21], ovarian cancer [31], osteosarcoma [46], pancreatic cancer [76], colorectal cancer [41], and lung adenocarcinoma [77].